In the pharmaceutical industry, compliance is not merely a regulatory checkbox; it is the bedrock of patient safety, market access, and international credibility. According to the World Health Organization, substandard and falsified medical products cause an estimated 267,000 deaths annually in low- and middle-income countries alone.
In global pharmaceuticals, filing a dossier is the starting line, not the finish line. True regulatory strength is defined by how consistently and efficiently a company secures market authorizations across different regulatory environments.
When a patient takes a medication, they trust that it will help them, not harm them. Behind that trust lies a complex, continuous process that operates silently in the background, monitoring every medicine throughout its lifecycle. This process is called pharmacovigilance, and its importance cannot be overstated.